SCHEMBL3365837

SCHEMBL3365837

CCC(CC)(C(=O)OCCOCCN1CCCC1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GAA P10253 2/20 0.53
HTT P42858 1/20 0.52
KDM4E B2RXH2 6/20 0.50
MAPT P10636 1/20 0.50
CHRM2 P08172 3/20 0.45
CHRM1 P11229 3/20 0.45
CHRM4 P08173 2/20 0.45
CHRM5 P08912 2/20 0.45
CHRM3 P20309 2/20 0.45
HTR1A P08908 2/20 0.45
CYP2D6 P10635 2/20 0.45
OPRM1 P35372 2/20 0.45
KCNH2 Q12809 2/20 0.45
DRD2 P14416 1/20 0.45
DRD1 P21728 1/20 0.45
HTR2A P28223 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3361921 0.99 HTT (0.54) ALDH1A1MEN1KMT2AGAAHTT
Piperilate SCHEMBL26493 0.77 ALDH1A1 (0.78) ALDH1A1MEN1KMT2AGAAHTT
Piperilate SCHEMBL1316709 0.77 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AGAAHTT
Oxeladin SCHEMBL405413 0.76 CHRM2 (0.64) ALDH1A1MEN1KMT2AGAAHTT
Piperilate SCHEMBL1650954 0.76 ALDH1A1 (0.76) ALDH1A1MEN1KMT2AGAAHTT
SCHEMBL3364929 0.75 CHRM2 (0.49) ALDH1A1MEN1KMT2AKDM4ECHRM2
SCHEMBL3362813 0.74 CHRM2 (0.51) MEN1KMT2AGAAKDM4ECHRM2
SCHEMBL25142218 0.73 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AGAAHTT
SCHEMBL3366202 0.73 CHRM2 (0.56) ALDH1A1MEN1KMT2AGAAHTT
SCHEMBL3366922 0.72 CHRM2 (0.49) MEN1KMT2AGAAKDM4ECHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009970-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES COMBINATORX (SINGAPORE) PTE. LTD. (SG) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009970-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES HTR1A, HTR3B, HTR3A ALDH1A1 2240/4885MEN1 3638/4885KMT2A 1108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.